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Varicella-zoster virus (VZV), the cause of varicella and zoster, is divided into ﬁve major clades and four provisional clades, the
latter of which have been rarely reported worldwide to date. We present a varicella outbreak by the provisional clade VI within an
Indian couple in Germany returning from a trip to Amsterdam. To the best of our knowledge, this is the ﬁrst case of varicella by
the VZV clade VI described in Germany, but the disease was acquired in The Netherlands.
1.Introduction
Varicella-zoster virus (VZV), a member of the genus Vari-
cellovirus within the subfamily Alphaherpesvirinae and the
Herpesviridae family, causes two distinct diseases. Primary
infection results in typical signs of varicella also termed as
chickenpox, and zoster is caused by endogenous reactivation
after the virus has established lifelong latency in trigeminal
and dorsal root ganglia. As a function of geographic distri-
bution, VZV has been separated into the ﬁve major clades 1–
5 conﬁrmed by full-genome sequencing. In addition, there
have been proposed four novel clades VI to IX still to
be conﬁrmed by further complete sequences [1, 2]. These
provisional clades have been rarely reported to date [2, 3].
Thepaperpresentedistheﬁrstdescriptionofvaricellacaused
by the VZV clade VI in Germany. This and the striking
clinical picture of relatively large bullous lesions of up to
8m mi nd i a m e t e rs e e mt ob ew o r t ht ob ep r e s e n t e da sac a s e
report.
2.CaseReport
2.1. Patients’ History. A married couple from India, a 32-
year-old man and a 25-year-old woman, was admitted to the
dermatologic clinic in July 2010 since both had developed
varicella. The woman was pregnant at week 34 of gestation.
In both patients, an immunodeﬁciency was not known. One
week before admission, the patients had visited a friend who
wasalsocomingfromIndia,buthewasapermanentresident
in Amsterdam, The Netherlands, at that time. Two days
after the meeting, the index case had developed a vesicular
exanthema, a typical clinical sign of varicella. However,
information on the possible source of the virus (contact
person) and the vesicular characteristics of the exanthema
was not available.
2.2. Clinical Examination. Seven days after the contact with
the index case, the Indian couple was admitted to the hospi-
tal. The man presented with diﬀuse exanthema consisting of2 Case Reports in Medicine
Table 1: Single-nucleotide polymorphisms in VZV strains of the novel provisional clade VI detected in two Indian patients with varicella in
comparison to other VZV clades. ORF: open reading frame, ND: not done.
Clades/
Reference
ORF 1 ORF 21 ORF 22 ORF 50 ORF 54 ORF 60
strains 508 685 790 33725 37902 38019 38055 38081 38177 87841 95241 101464
1/Dumas C G T T A G T A G C T C
2/pOka C A C C G G C C A T C C
2/vOka C A C C G G C C A T C C
3/VZV11 C G T C A G T A G T T C
4/VZV8 C A C C A G C C A T C C
5/CA123 C G C C A G T C G T C A
VI T T G C A G T C A T T C
VII ND ND ND ND ND G T C G ND C ND
VIII C A C C A G T C A T T C
IX C G C C A G C A G T C C
Indian patients T T G C A G T C A T T C
vesicleswithanarrowerythematousrimaswellasavesicular,
erosive enanthema of the oral mucosa. As a striking ﬁnding,
thereweresinglelargebullouslesions,measuringupto8mm
in diameter. Additionally, the patient suﬀered from fever and
adynamia.Thewomanshowedmultiplepapulovesicularskin
lesions. Overall, the male patient showed an initially severe
courseofvaricella,whereasthefemalepatienthadarelatively
mild course.
2.3. Laboratory Diagnostics. Routine blood testing revealed
hepatopathy with elevated serum concentration of alanine
aminotransferase (2.5x of reference) for the man. Testing
of vesicle ﬂuid for VZV DNA using polymerase chain
reaction [4] was positive in both patients. Sera were
tested for the presence of VZV-speciﬁc antibodies using
enzyme-linked immunoabsorbent assays Enzygnost Anti-
VZV/immunoglobulin (Ig) G and Anti-VZV/IgM (Siemens
Healthcare Diagnostics, Eschborn, Germany) at an early
point of time, 5 days after the ﬁrst cutaneous lesions
appeared. IgM und IgG were negative in the man, whereas
the woman’s IgM was positive and IgG was negative. Unfor-
tunately, a second serum sample from the convalescence
phase was not analyzed. The molecular-biological character-
ization of the virus using restriction fragment length poly-
morphism analysis of the open reading fames (ORF) 38
and 54 [5] as initial step revealed the wild-type VZV
pattern PstI+BglI−. Further characterization of ORFs 1, 21,
22, 50, 54, and 60 by the scattered single nucleotide poly-
morphism (SNP) method [6] resulted in typical SNPs of the
novel provisional VZV clade VI (Table 1) which was detected
in both patients.
2.3.1. Treatment and Course. The patients received acyclovir
intravenously at a dosage of 5mg per kg body weight 3
times daily for 7 days. The man was treated additionally with
systemic antibiotics. Zinc sulphate gel was used as topical
antiseptic therapy. Gynecological examination of the woman
showedaregularpregnancy.Bothpatientsrecoveredwithout
complications. Subsequently, the female patient gave mature
birth to a healthy child.
3. Discussion
Varicella is a common highly infectious disease with an
average age of manifestation diﬀering due to geographical
location. In Europe and North America, varicella is seen in
90% of the cases before the age of 10 years [7]. However,
in tropical and subtropical countries, such as in India,
varicella is occurring mostly in adolescents and young adults
[8]. VZV as the etiological agent of varicella represents
one viral serotype, but it is divided into diﬀerent genetic
clades due to viral evolution. The genomes of the ﬁve main
VZV clades characterized by the Arabic numerals 1–5 are
completely sequenced, while genome sequencing data for
the four provisional VZV clades assigned to the Roman
numerals VI to IX are partially incomplete [1–3]. Presently,
in Germany, the European clades 1 and 3 are prevailing in
varicella with a frequency of 30% and 46%, respectively,
followed by African/Indian clade 5 (21%) and clade 2 (0.9%)
causing varicella by the vaccine Oka strain after varicella
vaccination [9]. By contrast, VZV wild-type strains of clade
2 are typical for Japan and China [3].
Since the incubation period of varicella is up to 21 days,
it is beyond doubt that the Indian couple described in this
paperacquiredvaricelladuringtheirtriptoTheNetherlands.
Both patients developed the disease within one week after
VZV exposure to the index case. The novel provisional VZV
clade VI was identiﬁed as the etiological agent of varicella.
T h ep r o v i s i o n a lc l a d eV Ii sc o n s i d e r e dt ob eac o m b i n a t i o n
of the European clade 1 or 3 with the African/Indian clade 5
or clade 4 that has been found predominantly in countries
of South and Central America [3, 10]. Till now, clade VI
has been detected only in 11 cases in Europe, that is, two
cases in France, two cases in Italy, and seven cases in Spain
[10, 11]. In addition, there were four cases in Australia and
one case in Mexico [12–14]. To our knowledge, the two
patients of this paper are the ﬁrst cases of VZV infection byCase Reports in Medicine 3
clade VI described in Germany, but the virus was acquired
during a trip to Amsterdam. Since the index case was a
permanent citizen of The Netherlands at this time, it is
not clear if the virus circulates in The Netherlands or the
index case was infected by immigrants who imported the
virus from abroad. Thus, the future epidemiology of VZV
clades in varicella can be inﬂuenced continuously by travel
activities and migration, but also by vaccination policies,
with a presumptive subsequent inﬂuence upon herpes zoster
as a secondary VZV manifestation.
Two years ago, we observed a varicella outbreak in Indian
students in Magdeburg caused by the African/Indian VZV
clade 5 [15]. Clinically, varicella in these students was also
characterized by relative large bullous lesions up to 8mm in
diameter, similarly to the current male patient aﬀected by
VZV clade VI. This may give some reason to check future
cases carefully to ﬁnd out to what extent such relatively
large bullous lesions could indeed be clinically indicative of
infections caused by VZV clade 5 or VI. This is important
in so far as the diﬀerent major VZV clades have not been
distinguished by any diﬀerent virulence to date. However,
since the woman appeared to display more ordinary lesions,
the bullous lesions might also be related to host genetic or
other factors such as diﬀerences in viral loads that were not
analyzed. In conclusion, further clinical studies are required
to verify any associations between VZV clades and the
characteristics of cutaneous varicella lesions.
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